The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Committee Changes

29 Jul 2016 16:45

RNS Number : 7403F
Reckitt Benckiser Group PLC
29 July 2016
 

29 July 2016

RECKITT BENCKISER GROUP PLC

(The "Company" or "RB")

 

BOARD COMMITTEE CHANGES

 

The Company is pleased to announce the following changes to its standing Board Committees and their membership.

New Corporate Responsibility, Sustainability, Ethics and Compliance Committee

On the recommendation of the Nomination Committee, on 28 July 2016 the Board approved the establishment of a new Board committee to be known as the Corporate Responsibility, Sustainability, Ethics and Compliance Committee ("CRSEC Committee") with immediate effect. This new committee will support the Board in fulfilling its duty to safeguard and advance the Company's reputation for responsible and sustainable corporate conduct by reviewing, monitoring and assessing its approach to and management of corporate social responsibility, environmental and sustainability issues and behaviours, ethical conduct and regulatory compliance.

The CRSEC Committee will be chaired by Pam Kirby, and Adrian Bellamy and Nicandro Durante have been appointed as committee members. The CRSEC Committee will meet at least three times per year and at such other times as required. 

The Committee's terms of reference will be available on the Company's website at www.rb.com

Nomination Committee Membership

The Nomination Committee also recommended, and the Board approved, the appointment of Pam Kirby to the Nomination Committee with immediate effect. 

This disclosure is made in accordance with paragraph 9.6.11 of the Financial Conduct Authority's Listing rules.

 

For further Information:

Chris LoganCompany Secretary+44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations, Communications & External Affairs

+44 (0)1753 217 800

 

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

 

For more information visit www.rb.com

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEEFIUFMSELW
Date   Source Headline
31st Mar 202110:00 amRNSRB rebrands as Reckitt
26th Mar 202112:30 pmRNSDirector/PDMR Shareholding
17th Mar 20213:00 pmRNSDirector/PDMR Shareholding
4th Mar 20212:30 pmRNSDirector/PDMR Shareholding
3rd Mar 202110:00 amRNSDirector/PDMR Shareholding
1st Mar 20213:00 pmRNSDirector/PDMR Shareholding
1st Mar 20212:16 pmRNSTotal Voting Rights
25th Feb 20213:20 pmRNSDirector/PDMR Shareholding
24th Feb 20217:01 amRNSDisposal
24th Feb 20217:01 amRNSAcquisition
24th Feb 20217:00 amRNSFinal Results
1st Feb 202111:42 amRNSTotal Voting Rights
4th Jan 202112:39 pmRNSTotal Voting Rights
30th Dec 20209:21 amRNSTR-1: Notification of major holdings
17th Dec 202010:45 amRNSDirectorate Change
1st Dec 202011:30 amRNSTotal Voting Rights
25th Nov 202011:30 amRNSDirector/PDMR Shareholding
23rd Nov 20204:30 pmRNSDirector/PDMR Shareholding
2nd Nov 202011:10 amRNSTotal Voting Rights
21st Oct 20202:00 pmRNSDirector/PDMR Shareholding
20th Oct 20204:35 pmRNSPrice Monitoring Extension
20th Oct 20207:00 amRNS3rd Quarter Results
7th Oct 20203:00 pmRNSDirector Declaration
5th Oct 20204:00 pmRNSDirector/PDMR Shareholding
1st Oct 20202:34 pmRNSDirector/PDMR Shareholding
1st Oct 202011:38 amRNSTotal Voting Rights
1st Sep 202010:22 amRNSTotal Voting Rights
26th Aug 20201:05 pmRNSDisclosure of rights attached to equity shares
25th Aug 20204:00 pmRNSDirector/PDMR Shareholding
3rd Aug 202012:08 pmRNSTotal Voting Rights
28th Jul 20207:00 amRNSHalf-year Report
1st Jul 20209:17 amRNSTotal Voting Rights
30th Jun 20205:00 pmRNSDirector Declaration
23rd Jun 202010:00 amRNSDirectorate Change
5th Jun 20204:30 pmRNSDirector/PDMR Shareholding
1st Jun 202011:01 amRNSTotal Voting Rights
29th May 20204:41 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
29th May 20204:30 pmRNSDirector/PDMR Shareholding
29th May 202012:20 pmRNSDirector/PDMR Shareholding
28th May 20202:29 pmRNSDirector/PDMR Shareholding
13th May 20205:46 pmRNSDirector/PDMR Shareholding
13th May 20202:07 pmRNSPublication of Offering Memorandum
12th May 20206:01 pmRNSIssue of Debt
12th May 20204:55 pmRNSResult of AGM
12th May 20204:15 pmRNSDirectorate Change
4th May 20202:10 pmRNSDirector/PDMR Shareholding
1st May 20204:41 pmRNSDirector/PDMR Shareholding
1st May 202011:38 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSQ1 2020 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.